98 related articles for article (PubMed ID: 16940948)
1. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
Parize P; Chandesris MO; Lanternier F; Poirée S; Viard JP; Bienvenu B; Mimoun M; Méchai F; Mamzer MF; Herman P; Bougnoux ME; Lecuit M; Lortholary O
Antimicrob Agents Chemother; 2009 Mar; 53(3):1048-53. PubMed ID: 19104029
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Chabrol A; Cuzin L; Huguet F; Alvarez M; Verdeil X; Linas MD; Cassaing S; Giron J; Tetu L; Attal M; Récher C
Haematologica; 2010 Jun; 95(6):996-1003. PubMed ID: 20007135
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole-induced psychosis in rhino-orbital invasive aspergillosis.
Rekha HS; Paramasivam S; Raja K; Bharadwaj B
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37821144
[TBL] [Abstract][Full Text] [Related]
4. Extrapolating Antifungal Animal Data to Humans - Is it reliable?
Stevens VM; Mueller SW; Reynolds PM; MacLaren R; Kiser TH
Curr Fungal Infect Rep; 2020 Mar; 14(1):50-62. PubMed ID: 32201545
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice.
Hayashi R; Kitamoto N; Iizawa Y; Ichikawa T; Itoh K; Kitazaki T; Okonogi K
Antimicrob Agents Chemother; 2002 Feb; 46(2):283-7. PubMed ID: 11796331
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Therapies for Aspergillus spp.: Present and Future.
Eschenauer GA
Semin Respir Crit Care Med; 2024 Feb; 45(1):61-68. PubMed ID: 38151025
[TBL] [Abstract][Full Text] [Related]
7. Subacute invasive pulmonary aspergillosis after chemoradiotherapy for lung cancer.
Watanabe H; Shirai T; Saigusa M; Asada K; Arai K
Respirol Case Rep; 2020 Mar; 8(2):e00523. PubMed ID: 32025305
[TBL] [Abstract][Full Text] [Related]
8. Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications.
Mehravar S; Leite GS; Pimentel M; Rezaie A
Front Pharmacol; 2024; 15():1376656. PubMed ID: 38601473
[TBL] [Abstract][Full Text] [Related]
9. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
[TBL] [Abstract][Full Text] [Related]
10. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Spanakis EK; Aperis G; Mylonakis E
Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621
[TBL] [Abstract][Full Text] [Related]
11. [Efficacies and clinical roles of new antifungal agents].
Tokimatsu I; Kadota J
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Clemons KV; Espiritu M; Parmar R; Stevens DA
Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
[TBL] [Abstract][Full Text] [Related]
13. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
14. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
15. Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Harrison JM; Glickman RD; Ballentine CS; Trigo Y; Pena MA; Kurian P; Najvar LK; Kumar N; Patel AH; Sponsel WE; Graybill JR; Lloyd WC; Miller MM; Paris G; Trujillo F; Miller A; Melendez R
Doc Ophthalmol; 2005 Jan; 110(1):37-55. PubMed ID: 16249956
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
